Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDV-HXP-S Vaccine in Thailand
NCT04764422Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Patria in coronavirus disease 2019 (COVID-19), sponsored by Mahidol University. Started Mar 2021; status: completed.
02
Drugs
Patria
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04764422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764422.